InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
Thomas DesRosier
17 Aug 2026
See Remarks
Sold on a plan
82
$4.55
$373.10
Matthew R Henn
17 Aug 2026
See Remarks
Sold on a plan
81
$4.55
$368.55
Eric D. Shaff
17 Aug 2026
Director
Sold on a plan
263
$4.55
$1.20K
Kelly Brady
17 Aug 2026
See Remarks
Sold on a plan
64
$4.55
$291.20
Matthew R Henn
18 May 2026
See Remarks
Sold on a plan
77
$7.53
$579.81
Thomas DesRosier
18 May 2026
See Remarks
Sold on a plan
79
$7.53
$594.87
Eric D. Shaff
18 May 2026
Director
Sold on a plan
259
$7.53
$1.95K
Teresa L. Young
18 Aug 2025
See Remarks
Sold on a plan
59
$16.65
$982.35
Matthew R Henn
18 Aug 2025
See Remarks
Sold on a plan
73
$16.65
$1.22K
Thomas DesRosier
18 Aug 2025
See Remarks
Sold on a plan
76
$16.65
$1.27K
Eric D. Shaff
18 Aug 2025
Director
Sold on a plan
217
$16.65
$3.61K
Matthew R Henn
16 May 2025
See Remarks
Sold on a plan
77
$7.28
$560.56
Eric D. Shaff
16 May 2025
CEO and President
Sold on a plan
220
$7.28
$1.60K
Teresa L. Young
16 May 2025
See Remarks
Sold on a plan
63
$7.28
$458.64
Moltke Lisa von
18 Feb 2025
See Remarks
Sold on a plan
4,416
$0.81
$3.58K
Thomas DesRosier
18 Feb 2025
Chief Legal Officer and EVP
Sold on a plan
4,300
$0.81
$3.49K
Eric D. Shaff
18 Feb 2025
CEO and President
Sold on a plan
12,726
$0.81
$10.31K
Matthew R Henn
18 Feb 2025
See Remarks
Sold on a plan
3,953
$0.81
$3.20K
Teresa L. Young
18 Feb 2025
See Remarks
Sold on a plan
3,338
$0.81
$2.70K
Matthew R Henn
18 Nov 2024
See Remarks
Sold on a plan
927
$0.54
$501.23
Eric D. Shaff
18 Nov 2024
CEO and President
Sold on a plan
2,505
$0.54
$1.35K
Teresa L. Young
18 Nov 2024
See Remarks
Sold on a plan
735
$0.54
$397.64
Moltke Lisa von
18 Nov 2024
See Remarks
Sold on a plan
977
$0.54
$528.26
Thomas DesRosier
18 Nov 2024
Chief Legal Officer and EVP
Sold on a plan
878
$0.54
$474.73
Teresa L. Young
28 Oct 2024
See Remarks
Sold on a plan
2,983
$0.69
$2.06K
Eric D. Shaff
28 Oct 2024
CEO and President
Sold on a plan
8,748
$0.69
$6.04K
Thomas DesRosier
28 Oct 2024
Chief Legal Officer and EVP
Sold on a plan
4,259
$0.69
$2.94K
Matthew R Henn
28 Oct 2024
See Remarks
Sold on a plan
3,984
$0.69
$2.75K
Moltke Lisa von
28 Oct 2024
See Remarks
Sold on a plan
4,334
$0.69
$2.99K
David S. Ege
16 Aug 2024
See Remarks
Sold on a plan
1,128
$0.84
$947.52
Teresa L. Young
16 Aug 2024
See Remarks
Sold on a plan
728
$0.84
$611.52
Eric D. Shaff
16 Aug 2024
CEO and President
Sold on a plan
2,518
$0.84
$2.12K
Matthew R Henn
16 Aug 2024
See Remarks
Sold on a plan
923
$0.84
$775.32
Moltke Lisa von
16 Aug 2024
See Remarks
Sold on a plan
973
$0.84
$817.32
Thomas DesRosier
16 Aug 2024
Chief Legal Officer and EVP
Sold on a plan
873
$0.84
$733.32
Teresa L. Young
5 Aug 2024
See Remarks
Sold on a plan
24,480
$1.08
$26.53K
David Arkowitz
16 Feb 2024
Chief Financial Officer
Sold on a plan
3,939
$1.08
$4.25K
David S. Ege
16 Feb 2024
See Remarks
Sold on a plan
5,010
$1.08
$5.41K
Moltke Lisa von
16 Feb 2024
See Remarks
Sold on a plan
4,400
$1.08
$4.75K
Teresa L. Young
16 Feb 2024
See Remarks
Sold on a plan
3,374
$1.08
$3.64K
Matthew R Henn
16 Feb 2024
See Remarks
Sold on a plan
4,170
$1.08
$4.50K
Eric D. Shaff
16 Feb 2024
CEO and President
Sold on a plan
11,549
$1.08
$12.47K
Thomas DesRosier
16 Feb 2024
Chief Legal Officer and EVP
Sold on a plan
3,939
$1.08
$4.25K
Matthew R Henn
30 Oct 2023
See Remarks
Sold on a plan
3,886
$1.35
$5.25K
Moltke Lisa von
30 Oct 2023
See Remarks
Sold on a plan
4,232
$1.35
$5.71K
David S. Ege
30 Oct 2023
See Remarks
Sold on a plan
4,066
$1.35
$5.49K
Thomas DesRosier
30 Oct 2023
Chief Legal Officer and EVP
Sold on a plan
4,156
$1.35
$5.61K
David Arkowitz
30 Oct 2023
Chief Financial Officer
Sold on a plan
4,066
$1.35
$5.49K
Teresa L. Young
30 Oct 2023
See Remarks
Sold on a plan
2,907
$1.35
$3.92K
Eric D. Shaff
30 Oct 2023
CEO and President
Sold on a plan
8,552
$1.35
$11.55K
Paula Cloghessy
30 Oct 2023
See Remarks
Sold on a plan
2,904
$1.35
$3.92K
Show all 112 transactions →

What was left out

Form 4 filings counted 278
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 9,854,506
Sales filed before the plan box existed 20
History held since 29 Jun 2015